Does TUCATINIB Cause Malignant neoplasm progression? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Malignant neoplasm progression have been filed in association with TUCATINIB (TUKYSA). This represents 6.0% of all adverse event reports for TUCATINIB.
361
Reports of Malignant neoplasm progression with TUCATINIB
6.0%
of all TUCATINIB reports
37
Deaths
26
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TUCATINIB?
Of the 361 reports, 37 (10.2%) resulted in death, 26 (7.2%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 361 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
Decreased appetite (286)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TUCATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI